Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma lobbyists to EU: Cut deals with Trump
“The U.K. is the canary in the coal mine,” said Stephen Farrelly, global head of pharma and health care at ING, a Dutch bank. “The pressure is rising on the EU to do something similar.” Lobbyists for drug companies are…
Why AI Regulation In Pharma Manufacturing Matters More Than Ever
Nagesh Nama, CEO, xLM. Nagesh Nama is a seasoned technology executive with over 30 years of experience in life sciences. The release of the European Medicines Agency's Annex 22 on artificial intelligence represents a seismic shift in how AI will be…
December Healthcare Digital Edition Examines AI, Pharma Innovation and MedTech Strategy
The December editions of BizClik's Global Industries portfolio are now live, featuring fresh insights from Healthcare Digital. This month's issues spotlight global leaders, breakthrough technologies and the strategies shaping the future of…
Health and Finance ministries finalise PPO Plus to secure local pharma supply
Nation KUALA LUMPUR: The Health and Finance Ministries are finalising the Off Take Plus Programme agreement to secure local pharmaceutical supply and boost domestic investment. Health Minister Datuk Seri Dr Dzulkefly Ahmad said this includes…
Trump Tariff U-Turn: Zero-Tariff Pharma Deal Seals Win for UK Exports
In a dramatic reversal, Britain has secured a groundbreaking UK-US zero-tariff deal on pharmaceuticals, compelling US President Donald Trump to back down from his bold trade threats. The agreement, unveiled on 1 December 2025, underscores how…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Should You Sell?
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) shares gapped down before the market opened on Monday. The stock had previously closed at $83.05, but opened at $75.88. Zealand Pharma A/S shares last traded at $75.88, with a volume of 150…
XTX Topco Ltd Increases Stake in Ascendis Pharma A/S $ASND
XTX Topco Ltd boosted its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 61.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,066…
BridgeBio Pharma (NASDAQ:BBIO) Reaches New 52-Week High - What's Next?
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) hit a new 52-week high on Monday. The company traded as high as $72.47 and last traded at $71.7250, with a volume of 94503 shares trading hands. The stock had previously closed at $72.01.
Barbara Lavernos on Beauty's Radical Transformation: Personalization, Sustainability, and Science and Technology's Convergence
Barbara Lavernos may have been at L'Oréal for 34 years, but she has never seen such radical shifts in the beauty industry as there are currently. “The last years have been accelerating in terms of change like never before.
Zero-tariff deal with US to cost NHS £1 billion, No 10 says
Sign up for our email featuring expert insight and funding opportunities for entrepreneurs and SMEs I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. A deal that gives the US zero tariffs on…
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Evercore 8th Annual Healthcare Conference December 2, 2025 8:20 AM EST James Hippel - Executive VP of Finance & CFO David Clair - VP of Investor Relations & Corporate Development Daniel Markowitz - Evercore ISI…
Jim Cramer's top 10 things to watch in the stock market Tuesday
My top 10 things to watch Tuesday, Dec. 2 1. Stocks were headed for a higher open this morning, supported by tech and AI-linked names. Club holdings Broadcom and Nvidia were both up. Investors are also looking ahead to next week's Fed meeting, with…
Stock Market Today: Nifty50, BSE Sensex Open Under Pressure Amid Weak Rupee, FPI Outflows
The domestic share market opened on a weak note on Tuesday as both the benchmark indices slipped into negative territory, weighed down by a falling rupee and continued foreign portfolio investor (FPI) outflows. The Nifty 50 index opened at…
Strategic Expansion: Laboratoire Suisse and Cosmetic Import Continue Their Growth with the Acquisition of Les Laboratoires Colba's Assets
BOUCHERVILLE, QC, Dec. 2, 2025 /CNW/ - The JAMP Pharma Group, a Canadian leader in the pharmaceutical sector, announced today that its over-the-counter natural health and cosmetic products division, through its subsidiaries Laboratoire Suisse Inc.
Zero-tariff deal with US to cost NHS £1 billion, No 10 says
A deal that gives the US zero tariffs on its imports of UK pharmaceuticals in return for the NHS raising spending on medicines will cost around £1 billion, Downing Street has said. The agreement sees the UK's threshold for what it can pay for…
Receive a Daily briefing on Pharma Industry News
Get Started